Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Y Kang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Internal Medicine Journal|May 3, 2020
Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetesMatthew J L Hare, Jessica M Deitch, Matthew J Y Kang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 26, 2026
Beyond black-box AI: Interpretable hybrid systems for dementia careMatthew J Y Kang, Wenli Yang, Monica R Roberts, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2026
Systematic review and meta-analysis of associations between neuropsychiatric symptoms and amyloid, tau, neuronal, and glial biomarkers in young-onset dementiasWei-Hsuan Chiu, Matthew J Y Kang, Anita M Y Goh, et al.
Schizophrenia Research|April 6, 2024
Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosisMatthew J Y Kang, Dhamidhu Eratne, Cassandra Wannan, et al.
International Psychogeriatrics|February 9, 2023
Carer burden and behavioral disturbance is similar between younger-onset Alzheimer's disease and behavioral variant frontotemporal dementiaMatthew J Y Kang, Sarah Farrand, Andrew Evans, et al.
Australian Health Review : a Publication of the Australian Hospital Association|May 5, 2025
The Hospital Harmony program improves interdisciplinary healthcare team functioning and communicationMatthew J Y Kang, Ar Kar Aung, Rob Selzer, et al.
Acta Neuropsychiatrica|December 23, 2025
Distinct contributions of cerebrospinal fluid biomarkers to cognitive impairment and neuropsychiatric symptoms in young-onset dementiaWei-Hsuan Chiu, Anita M Y Goh, Dhamidhu Eratne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2025
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's diseaseMatthew J Y Kang, Dhamidhu Eratne, Samantha M Loi, et al.
Bipolar Disorders|April 23, 2025
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and AstrogliosisMatthew J Y Kang, Dhamidhu Eratne, Olivia Dean, et al.
Journal of the Neurological Sciences|November 22, 2024
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disordersDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Internal Medicine Journal|May 3, 2020
Clinical, psychological and demographic factors in a contemporary adult cohort with diabetic ketoacidosis and type 1 diabetesMatthew J L Hare, Jessica M Deitch, Matthew J Y Kang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 26, 2026
Beyond black-box AI: Interpretable hybrid systems for dementia careMatthew J Y Kang, Wenli Yang, Monica R Roberts, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2026
Systematic review and meta-analysis of associations between neuropsychiatric symptoms and amyloid, tau, neuronal, and glial biomarkers in young-onset dementiasWei-Hsuan Chiu, Matthew J Y Kang, Anita M Y Goh, et al.
Schizophrenia Research|April 6, 2024
Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosisMatthew J Y Kang, Dhamidhu Eratne, Cassandra Wannan, et al.
International Psychogeriatrics|February 9, 2023
Carer burden and behavioral disturbance is similar between younger-onset Alzheimer's disease and behavioral variant frontotemporal dementiaMatthew J Y Kang, Sarah Farrand, Andrew Evans, et al.
Australian Health Review : a Publication of the Australian Hospital Association|May 5, 2025
The Hospital Harmony program improves interdisciplinary healthcare team functioning and communicationMatthew J Y Kang, Ar Kar Aung, Rob Selzer, et al.
Acta Neuropsychiatrica|December 23, 2025
Distinct contributions of cerebrospinal fluid biomarkers to cognitive impairment and neuropsychiatric symptoms in young-onset dementiaWei-Hsuan Chiu, Anita M Y Goh, Dhamidhu Eratne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2025
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's diseaseMatthew J Y Kang, Dhamidhu Eratne, Samantha M Loi, et al.
Bipolar Disorders|April 23, 2025
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and AstrogliosisMatthew J Y Kang, Dhamidhu Eratne, Olivia Dean, et al.
Journal of the Neurological Sciences|November 22, 2024
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disordersDhamidhu Eratne, Matthew J Y Kang, Courtney Lewis, et al.
Pageof 2